// App-Quantinova.ai

939 : Genetic and Metabolic Determinants of Methotrexate Induced Mucositis in Pediatric Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Marissa den Hoed

Principal Investigators

  • E. Lopez-Lopez

  • Mariel L. Te Winkel

  • Marry M. van den Heuvel-Eibrink

  • Wim Tissing

  • Jasmijn de Rooij

  • A. Gutierrez-Camino

  • A. Garcia-Orad

  • E. den Boer

  • Rob Pieters

  • S.M.F. Pluijm

  • R. de Jonge

Medical Centers

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Medical Center Groningen, Groningen, Netherlands

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Princess Maxima Center, Utrecht, Netherlands

  • Department of Clinical Chemistry, Erasmus MC-Sophia Childrens Hospital, Rotterdam, Netherlands

  • University of the Basque Country (UPV/EHU), Leioa, Spain

  • Erasmus University Medical Center, Rotterdam, Netherlands

  • Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands

  • Erasmus MC-Sophia Childrens Hospital, Rotterdam, Netherlands

Locations

  • Spain

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mucositis

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Methotrexate

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final